Publications

Publications

Filter Results: (258) Arrow Down

Show Results For

Hamermesh, Richard G.Remove Hamermesh, Richard G. →

Page 1 of 258 Results →
  • (Revised May 2024)
  • Teaching Note

Lyric Dinner Theater (A) and (B)

By: Richard G. Hamermesh, Jim Sharpe and Noah Fisher
This teaching note is associated with HBS cases 813-043 and 813-044. View Details
Keywords: Turnarounds; Turnaround; Operations Management; Family Business; Family-owned Business; Hiring; Careers; Sales; Operations; Entrepreneurship; Negotiation; Entertainment and Recreation Industry; Saint Louis
Related
  • January 17, 2022
  • Article

Reducing Racial Disparities in Cancer Outcomes

By: Kathy Giusti and Richard G. Hamermesh
A disproportionate number of Black patients die from cancer in the United States. A key to addressing this problem is enrolling more Black patients in clinical trials. A strategy consisting of these three parts can help accomplish this goal: 1) centralize information... View Details
Keywords: Cancer Trials; Racial Disparity; Health Testing and Trials; Race; Strategy
Related
  • June 11, 2021
  • Article

Addressing Demographic Disparities in Clinical Trials

By: Kathy Giusti, Richard G. Hamermesh and Mark Krasnow
Disparities in health care are not just limited to the delivery of care. They also exist in the way that clinical trials are structured. Women, people of color, and the elderly often are not adequately represented. This article offers three strategies for addressing... View Details
Keywords: Health Testing and Trials; Demographics
Related
  • September 30, 2020
  • Article

How Nonprofit Foundations Can Sustainably Fund Disease Research

By: Richard G. Hamermesh and Kathy Giusti
Related
  • August 18, 2020
  • Article

What It Takes to Lead a Disease Research Foundation

By: Richard G. Hamermesh and Kathy Giusti
Related
  • June 2020
  • Case

Breakthroughs at Blueprint Medicines

By: Richard G. Hamermesh, Kathy Giusti and Susie L. Ma
Precision medicine company Blueprint Medicines was building a successful track record for bringing drug therapies to market 40% faster than average. The company had spent $40 million dollars and two years building a compound library that became its drug development... View Details
Keywords: Precision Medicine; Cancer; Biotechnology; Drug Development; Strategy; Expansion; Science; Genetics; Information Technology; Entrepreneurship; Organizational Culture; Management; Growth and Development; Pharmaceutical Industry; United States; Cambridge; Massachusetts
Related
  • March 6, 2020
  • Article

How Medical Nonprofits Set Winning Strategy

By: Kathy Giusti and Richard G. Hamermesh
Related
  • Article

How Harvard Business School Is Advancing Precision Medicine

By: Kathy Giusti and Richard G. Hamermesh
Related
  • September 2019
  • Case

Dementia Discovery Fund

By: Richard G. Hamermesh, Kathy Giusti and Sarah Gulick
The case is set in March 2019, and tells the story of the founding of the Dementia Discovery Fund (DDF). The idea for the fund began in 2015, when then-Prime Minister David Cameron spoke about the importance of making breakthroughs in dementia research, and pledged... View Details
Keywords: Venture Capital; Investment Funds; Mission and Purpose; Recruitment; Health Care and Treatment; Pharmaceutical Industry; Financial Services Industry; Boston; Massachusetts; London; England
Related
  • July 2019 (Revised July 2019)
  • Teaching Note

Intermountain Healthcare: Pursuing Precision Medicine

By: Richard G. Hamermesh, Robert S. Huckman and Julia Kelley
Related
  • June 4, 2019
  • Article

Finding the Sweet Spot: Why Industry, Nonprofits Should (or Can) Collaborate on Master Protocols

By: Richard G. Hamermesh, Kathy Giusti and Bradley Smith
Related
  • 28 Feb 2019
  • Interview

Pursuing Precision Medicine at Intermountain Healthcare

By: Richard G. Hamermesh and Brian Kenny
Related
  • February 25, 2019
  • Article

Impact Investing: A New Way to Fund Cures for Cancer

By: Richard G. Hamermesh and Kathy Giusti
Related
  • December 12, 2018
  • Article

Impact Investing Could Accelerate the Fight Against Cancer

By: Richard G. Hamermesh and Kathryn E. Giusti
Related
  • November 12, 2018
  • Article

Precision Medicine Has Transformed Cancer Treatment. Here's How to Move It Beyond Oncology

By: Richard G. Hamermesh and Kathy Giusti
Related
  • October 4, 2018
  • Article

Precision Medicine Needs a Business Mindset in Order to Flourish

By: Richard G. Hamermesh and Kathryn E. Giusti
Related
  • May 2018
  • Case

The Multiple Myeloma Research Foundation's Answer Fund

By: Richard G. Hamermesh and Matthew G. Preble
Keywords: Data Analytics; Customer Focus and Relationships; Customer Relationship Management; Cost vs Benefits; Investment Return; Health Care and Treatment; Innovation Leadership; Intellectual Property; Knowledge Sharing; Knowledge Dissemination; Leadership; Leading Change; Resource Allocation; Goals and Objectives; Marketing Communications; Performance; Programs; Projects; Business and Community Relations; Business and Stakeholder Relations; Networks; Partners and Partnerships; Research and Development; Genetics; Behavior; Motivation and Incentives; Social and Collaborative Networks; Nonprofit Organizations; Strategy; Health Industry; Pharmaceutical Industry; Biotechnology Industry; United States
Related
  • Article

Master Protocols in Oncology: A Review of the Landscape

By: Bradley Smith, Kathy Giusti, Richard G. Hamermesh and Dixie-Lee Esseltine
Related
  • April 2018
  • Case

Hawk Electronics, Inc.

By: Richard G. Hamermesh and John J. Lafkas
Hawk Electronics ("Hawk") presents the problems that a company can encounter when its divisions have distinct strategies, especially when one division has been favored at another's expense. It also highlights how such problems can reflect cognitive biases, which... View Details
Keywords: Business Divisions; Resource Allocation; Strategy; Innovation and Management
Related
  • April 2018
  • Teaching Note

Hawk Electronics, Inc. (Brief Case)

By: Richard G. Hamermesh and John J. Lafkas
Teaching Note for HBS Brief Case 918-521. View Details
Related